[HTML][HTML] Serial prostate magnetic resonance imaging fails to predict pathological progression in patients on active surveillance

D Omil-Lima, A Kim, I Weinstein, K Gupta… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
Methods Patients on AS with≥ 2 prostate MRI and≥ 2 prostate biopsies were included.
Prostate Imaging-Reporting and Data System (PI-RADS) score upgrade, as assigned by …

Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed …

RR Flavell, AC Westphalen, C Liang, CC Sotto… - Abdominal …, 2014 - Springer
Purpose To determine the ability of multiparametric MR imaging to predict disease
progression in patients with prostate cancer managed by active surveillance. Methods Sixty …

Changes in magnetic resonance imaging using the prostate cancer radiologic estimation of change in sequential evaluation criteria to detect prostate cancer …

LP O'Connor, AZ Wang, NK Yerram, L Long… - European urology …, 2021 - Elsevier
Background The ability of serial magnetic resonance imaging (MRI) to capture pathologic
progression during active surveillance (AS) remains in question. Objective To determine …

Diagnostic accuracy and prognostic value of serial prostate multiparametric magnetic resonance imaging in men on active surveillance for prostate cancer

CE Chu, JE Cowan, PE Lonergan… - European Urology …, 2022 - Elsevier
Background Multiparametric magnetic resonance imaging (MRI) is increasingly utilized to
improve the detection of clinically significant prostate cancer. Evidence for serial MRI in men …

MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer

M Marras, JL Ellis, O Copelan, U Naha, T Han… - … Oncology: Seminars and …, 2024 - Elsevier
Objectives Active surveillance (AS) is a management strategy for patients with favorable risk
prostate cancer. Multi-parametric magnetic resonance imaging (mpMRI) may impact …

[HTML][HTML] Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective …

B Valentin, C Arsov, T Ullrich, R Al-Monajjed… - European Urology Open …, 2024 - Elsevier
Background Multiparametric magnetic resonance imaging (mpMRI) may allow patients with
prostate cancer (PC) on active surveillance (AS) to avoid repeat prostate biopsies during …

Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance

GT Chesnut, EA Vertosick, N Benfante, DD Sjoberg… - European urology, 2020 - Elsevier
Background Active surveillance (AS) protocols rely on rectal examination, prostate-specific
antigen, imaging, and biopsy to identify disease progression. Objective To evaluate whether …

REPEATED MRI SCANS DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: NATURAL HISTORY OF PROSTATIC LESIONS AND UPGRADING RATES …

S Luzzago - 2021 - air.unimi.it
Objectives To test upgrading rates in patients on Active Surveillance (AS) for prostate cancer
(PCa) after serial multiparametric magnetic resonance imaging (mpMRI) scans. Materials …

The Magnetic Resonance Imaging in Active Surveillance (MRIAS) trial: use of baseline multiparametric magnetic resonance imaging and saturation biopsy to reduce …

A Amin, MJ Scheltema, R Shnier, A Blazevski… - The Journal of …, 2020 - auajournals.org
Purpose: Prospective studies are lacking in assessing the diagnostic utility of serial
multiparametric magnetic resonance imaging to predict biopsy proven progression to …

4-year outcomes from an MP-MRI based active surveillance programme-PSA dynamics and serial MRI scans allow omission of protocol biopsies

KM Gallagher, E Christopher, AJ Cameron… - BJU …, 2018 - research.ed.ac.uk
Objectives This study aimed to report outcomes from a multi‐parametric MRI (MP‐MRI)
based active surveillance programme that did not perform protocol biopsies after the first …